SEC Filings TLDR

This filing is Amendment No. 8 to Schedule 13D/A by RA Capital Management, L.P. regarding its holdings in VOR Biopharma Inc. The amendment updates the ownership details and transactions involving the common stock of VOR Biopharma Inc. RA Capital Management, L.P., along with Peter Kolchinsky and Rajeev Shah, collectivel...

OrbiMed Advisors LLC and OrbiMed Capital GP V LLC have filed Amendment No. 3 to Schedule 13D, reporting a decrease in their beneficial ownership of PMV Pharmaceuticals, Inc. common stock by more than 1%. As of October 27, 2025, OrbiMed Private Investments V, LP (OPI V) holds 4,975,291 shares, representing approximately...

OrbiMed Advisors LLC and OrbiMed Capital GP V LLC filed Amendment No. 3 to Schedule 13D, reporting a decrease in their beneficial ownership of PMV Pharmaceuticals, Inc. common stock by more than 1%. As of October 27, 2025, OrbiMed Private Investments V, LP (OPI V) holds 4,975,291 shares, representing approximately 9.4%...

Trian Fund Management, L.P., along with General Catalyst Group Management, LLC, has submitted a non-binding proposal to acquire all outstanding ordinary shares of Janus Henderson Group plc not currently owned by Trian. The proposed acquisition price is $46.00 per share in cash, representing a significant premium to the...

Voss Capital, LLC has filed Amendment No. 3 to its Schedule 13D regarding its holdings in International Money Express, Inc. (IMXI). The amendment reflects a significant reduction in Voss Capital's ownership, decreasing from 5.6% to 2.6% of the outstanding shares. The shares were sold through various transactions over t...

This Amendment No. 1 to Schedule 13D, filed by Mir Imran and InCube Labs, L.L.C., updates the ownership details of Class A Common Stock of Rani Therapeutics Holdings, Inc. The amendment includes information on a private placement where Mir Imran purchased 2,083,334 shares of Class A Common Stock and 2,083,334 warrants ...

Fairmount Funds Management LLC and Fairmount Healthcare Fund II GP LLC filed Amendment No. 7 to their Schedule 13D regarding their holdings in Viridian Therapeutics, Inc. The amendment reports that the Reporting Persons have voting and dispositive power over 16,025,330 shares of Common Stock, representing 15.14% of the...

Perceptive Advisors LLC has filed an amendment to its Schedule 13D, disclosing an increased stake in Trinity Biotech plc. The filing reveals that Perceptive Advisors LLC now holds 100,800,000 Class A Ordinary Shares, representing a 22.5% ownership in the company. This marks a significant increase from their previous ho...

This Amendment No. 40 to the Schedule 13D, filed by Broadwood Partners, L.P., amends and supplements the original Schedule 13D filed on October 12, 2004, regarding the common stock of STAAR Surgical Company. The amendment includes details about the submission of appraisal demands for 13,519,491 shares beneficially owne...

Amendment No. 1 to Schedule 13D filed by Wing Luk CHAN for Nature Wood Group Limited (NWGL) discloses the disposition of all 7,516,484 ordinary shares held by the reporting person. The shares were sold in a private transaction on October 22, 2025, at a price of $0.0592 per share, totaling approximately $6.8 million. Th...

This Amendment No. 1 to Schedule 13D, filed by Qing Cai HUANG, reflects the disposition of the Reporting Person's entire beneficial ownership of ordinary shares of Nature Wood Group Limited (the "Issuer"). The transaction occurred on October 22, 2025, pursuant to a share purchase agreement. The Reporting Person dispose...

This Amendment No. 1 to the Schedule 13D filed by WE-INN LLC, Gregory D. Wasson, and Kimberly Wasson updates the ownership details of Innventure, Inc.'s Common Stock. The Reporting Persons have sold a total of 895,810 shares in open market transactions between October 10, 2025, and October 24, 2025, at prices ranging f...

This filing, Amendment No. 10 to Schedule 13D, pertains to the Common Stock of Hall of Fame Resort & Entertainment Company. The amendment updates the Schedule 13D initially filed on July 14, 2020, and includes information on the termination and extension of the Merger Agreement. On October 22, 2025, the Issuer received...

This Amendment No. 8 to the Schedule 13D for Grindr Inc. discloses the Reporting Persons' intention to explore the possibility of acquiring the Issuer in a going private transaction. The Reporting Persons, including James Fu Bin Lu and entities controlled by him, propose to acquire all outstanding shares of Grindr Inc....

James Fu Bin Lu and George Raymond Zage III, along with their affiliated entities, have submitted a non-binding proposal to acquire all outstanding shares of Grindr Inc. not already owned by them. The offer price is $18.00 per share, representing a 51% premium over the stock price on October 10, 2025. The acquisition w...

Gamco Investors, Inc. and related entities have filed an amended Schedule 13D/A, disclosing an increased ownership in Farmer Brothers Co. The filing reports that Gamco Investors now holds 1,346,809 shares, representing 6.3% of the outstanding common stock. This marks a significant increase from their previous holdings,...

This Amendment No. 3 to Schedule 13D, filed by O'Connor, a distinct business unit of UBS Asset Management Americas (LLC), updates the ownership details of Common Shares of Electra Battery Materials Corp. The amendment reports that the reporting person holds 9,278,996 Common Shares, representing 9.9% of the outstanding ...

Whitebox Advisors LLC filed a Schedule 13D/A amendment disclosing significant restructuring of its position in Electra Battery Materials Corp (ELBM). The firm exchanged $31.9 million in convertible notes for 8.97 million common shares, 28.9 million warrants exercisable at $1.25/share, 21.9 million pre-funded warrants, ...

This filing represents Amendment No. 4 to the Schedule 13D for Daktronics Inc., submitted by Alta Fox Opportunities Fund, LP and related entities. The amendment updates several sections, including the source of funds used for purchasing shares, the purpose of the transactions, and the number of shares beneficially owne...

This Amendment No. 1 to Schedule 13D, filed on behalf of the Reporting Persons, amends and supplements the Schedule 13D filed on July 14, 2025. The amendment primarily addresses the termination of the Reporting Persons' informal understanding to act as a 'group' for purposes of Regulation 13D with respect to the Class ...

Cormorant Asset Management, LP, along with its affiliated entities, has filed an amendment to its Schedule 13D, indicating a significant reduction in its stake in Biomea Fusion, Inc. The filing, dated October 24, 2025, reveals that the Reporting Persons sold a total of 2,620,872 shares of Common Stock in open-market tr...

This Amendment No. 1 to Schedule 13D, dated October 24, 2025, amends and supplements the Initial Statement filed on September 23, 2025, by Brent D. Baird. The amendment reflects changes in ownership of Common Stock since the Initial Statement. Brent D. Baird purchased 1,009,310 shares of Common Stock with personal fund...

This filing is Amendment No. 9 to the Schedule 13D originally filed on March 22, 2024, for Vertical Aerospace Ltd. The amendment updates the ownership details of the Ordinary Shares, par value $0.001 per share, of Vertical Aerospace Ltd. The filing includes transactions made by the reporting person through Winterflood ...

This filing is Amendment No. 4 to the Schedule 13D originally filed on December 23, 2024, by the Reporting Persons, relating to the Common Stock of Universal Safety Products, Inc. The amendment updates the beneficial ownership details of the Reporting Persons, including Ault & Company, Inc., Alpha Structured Finance LP...

This Amendment No. 8 to the Schedule 13D filed by Khosla Ventures and related entities provides updated information on their ownership of Rocket Lab Corporation's common stock. The filing details the distribution of 5,500,000 shares of common stock by Khosla Ventures V, L.P. (KV V) to its underlying limited partners an...